Health · 1 views
Link between liver fibrosis in MASLD, ASCVD varies by glycemic status
A recent study has found a link between liver fibrosis in patients with metabolic dysfunction-associated steatotic liver disease (MASLD)…
AI Summary
A recent study has found a link between liver fibrosis in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and atherosclerotic cardiovascular disease (ASCVD). The relationship between liver fibrosis and ASCVD in MASLD patients is influenced by their glycemic status. This indicates that the severity of liver fibrosis and its connection to cardiovascular disease may differ depending on a patient's blood sugar levels. The study's findings suggest that the association between liver fibrosis and ASCVD in MASLD patients is complex and may be affected by various factors, including glycemic status.
Read full article on MedicalxpressAI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedEnjoyed this article? Consider supporting HappeningNow to help keep independent AI-powered news analysis moving forward. Your contribution helps cover infrastructure, AI summaries, and continued platform development.
Support HappeningNowMore from Health
Continue reading recent Health coverage
- Metabolic dysfunction-associated steatotic liver disease linked to higher odds of eosinophilic esophagitisContinue reading
- Nicotine levels are rising among teens who vape, new study warnsContinue reading
- A third of patients with chronic rhinosinusitis with nasal polyps exhibit anxiety symptomsContinue reading